Lilly Among MNCs Scouting In Turkey For Local Partners As GMP Inspection Backlog Continues
This article was originally published in PharmAsia News
Executive Summary
Eli Lilly & Co. Inc. has been rumored to be in partnership talks with Turkish Mustafa Nevzat Pharmaceuticals. The U.S. drug maker is reportedly looking for a minority stake in the Turkish generics maker
You may also be interested in...
IEIS Secretary General Turgut Tokgoz On The Future Of Turkish Pharma: An Interview With PharmAsia News (Part 2 of 2)
In the midst of negotiations over the government’s next pharmaceutical budget, the leader of the Pharmaceutical Manufacturers Association of Turkey sits down to talk about price cuts, GMP requirements and the future of the Turkish pharma industry.
IEIS Secretary General Turgut Tokgoz On The Future Of Turkish Pharma: An Interview With PharmAsia News (Part 1 of 2)
In the midst of negotiations over the government’s next pharmaceutical budget, the leader of the Pharmaceutical Manufacturers Association of Turkey sits down to talk about price cuts, GMP requirements and the future of the Turkish pharma industry.
Amgen Shrugs Off Turkish Price Cuts, Snatches Up Mustafa Nevzat For Broader Reach Into Emerging Markets
Despite harsh price cuts in Turkey that have taken a toll on multinationals, Amgen dives head first into the market.